BeStock  
Stocks › Biotechnology › ACAD

ACADIA Pharmaceuticals ACAD

US equityMarket cap rank #2441Biotechnology
$17.11 −$0.48 (-2.73%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $17.12 +0.06%
Open$17.47
Prev close$17.59
Day range$17.05 – $17.79
Volume1.90M
Market cap$2.96B
P/E (TTM)8.1
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership100.2%+0.60 pts vs. prior quarter
Institutions holding428+1 vs. prior quarter
Insider trades (recent)35 buys / 15 sellsNet buying
Short interest4.83% of floatDays to cover 5.9 · as of 30 Oct 2026
Short-sale volume share19.5%5-day average of daily volume

Short-sale volume as % of daily volume

4%12%20%29%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$36.06M (5 inflow days, 15 outflow days).

Net flow by order size, last 20 sessions

−$28.0MSuper−$8.0MBig−$8.7MMid−$3.5MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 52.1% of shares outstanding.

Largest holders

  • Baker Bros. Advisors LP24.83%
  • BlackRock13.28%
  • Vanguard Portfolio Management, LLC5.47%
  • State Street Global Advisors4.43%
  • RTW Investments, LP4.13%
  • Vanguard Capital Management, LLC3.35%
  • Geode Capital Management, LLC1.95%
  • Dimensional Fund Advisors1.95%

By investor type

  • Mutual Fund52.60%
  • Hedge Fund40.63%
  • Public Company2.69%
  • Government Pension Fund1.14%
  • VC/PE Fund0.97%
  • Sovereign Wealth Fund0.96%
  • Individual/Insider0.55%
  • Private Company0.55%

Reported short interest has fallen from 5.50% to 4.83% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +618,674 5.5%
Morgan Stanley Public Company 2026/Q3 +534,048 0.9%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +534,048 0.9%
BlackRock Mutual Fund 2026/Q3 +432,308 13.3%
Allspring Global Investments, LLC Mutual Fund 2026/Q3 +397,834 0.9%
Y-Intercept (Hong Kong) Limited Mutual Fund 2026/Q3 +382,749 0.2%
Los Angeles Capital Management LLC Mutual Fund 2026/Q3 +340,082 0.2%
Assenagon Asset Management S.A. Mutual Fund 2026/Q3 +313,504 0.2%
UBS Asset Management Mutual Fund 2026/Q3 +274,171 0.6%
PanAgora Asset Management, Inc. Mutual Fund 2026/Q3 +235,875 0.5%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +258,702 0.5%
Marshall Wace LLP Hedge Fund 2026/Q3 +1,688,651 1.0%
Citadel Advisors LLC Hedge Fund 2026/Q3 +1,559,417 1.3%
Qube Research & Technologies Ltd Mutual Fund 2026/Q3 +1,496,311 1.4%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +968,101 1.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
29 Oct 2026 Mark Schneyer Chief Financial Officer Automatic Disposition -3,321 $20.88 71,322
14 Oct 2026 Mark Schneyer Chief Financial Officer Other Acquisition +6,815 – 71,322
5 Aug 2026 Mark Schneyer Chief Financial Officer Derivative Exercise and Sale -20,141 $29.34 67,828
4 Aug 2026 Mark Schneyer Chief Financial Officer Intent to Sell (Form 144) -5,849 $27.15 –
29 Jul 2026 Elizabeth H. Thompson Former Head of Research & Development Derivative Exercise and Sale -16,558 $26.17 18,994
28 Jul 2026 Elizabeth H. Thompson Former Head of Research & Development Derivative Exercise and Retained +15,714 – 18,994
25 Jun 2026 James Kihara Officer Automatic Disposition -11,421 $26.08 13,088
28 May 2026 Laura Brege Independent Director Other Derivative Acquisition +9,311 – 9,311
28 May 2026 Laura Brege Independent Director Other Derivative Acquisition +16,004 $21.66 16,004
28 May 2026 Laura Brege Independent Director Derivative Exercise and Retained +8,107 – 23,202
28 May 2026 Julian Baker Independent Director Other Derivative Acquisition +64,016 $21.66 32,008
28 May 2026 Edmund Harrigan Independent Director Other Derivative Acquisition +9,311 – 9,311
28 May 2026 Edmund Harrigan Independent Director Other Derivative Acquisition +16,004 $21.66 16,004
28 May 2026 Edmund Harrigan Independent Director Derivative Exercise and Retained +8,107 – 43,148
28 May 2026 James Daly Independent Director Other Derivative Acquisition +9,311 – 9,311
28 May 2026 James Daly Independent Director Other Derivative Acquisition +16,004 $21.66 16,004
28 May 2026 James Daly Independent Director Derivative Exercise and Retained +8,107 – 12,148
28 May 2026 Baker Bros. Advisors LP Other Acquisition +37,244 – 37,244
28 May 2026 Jonathan Poole Independent Director Other Derivative Acquisition +9,311 – 9,311
28 May 2026 Jonathan Poole Independent Director Other Derivative Acquisition +16,004 $21.66 16,004

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 8,317,392 4.8% 5.9
15 Oct 2026 9,094,151 5.3% 4.6
30 Sep 2026 8,275,918 4.8% 2.9
15 Sep 2026 9,666,972 5.6% 7.2
31 Aug 2026 9,739,720 5.7% 6.9
14 Aug 2026 9,478,912 5.5% 4.5

Discussion

No comments yet — be the first to weigh in on ACAD.

Sign in to join the discussion.

Scroll to Top